S-nitrosation and regulation of inducible nitric oxide synthase
S-nitrosation and regulation of inducible nitric oxide synthase
复制标题
DOI:
10.1021/bi0474463
复制
发表时间:
2005-03-29
期刊:
影响因子:
2.9
通讯作者:
Marletta, MA
中科院分区:
文献类型:
--
作者:
Mitchell, DA;Erwin, PA;Marletta, MA
The inducible isoform of nitric oxide synthase (iNOS) and three zinc tetrathiolate mutants (C104A, C109A, and C104A/C109A) were expressed in Escherichia coli and purified. The mutants were found by ICP-AES and the zinc-specific PAR colorimetric assay to be zinc free, whereas the wild-type iNOS zinc content was 0.38 +/- 0.01 mol of Zn/mol of iNOS dimer. The cysteine mutants (C104A and C109A) had an activity within error of wild-type iNOS (2.24 +/- 0.12 mu mol of NO min(-1) mg(-1)), but the double cysteine mutant had a modestly decreased activity (1.75 +/- 0.14 mu mol of NO min(-1) mg(-1)). To determine if NO could stimulate release of zinc and dimer dissociation, wild-type protein was allowed to react with an NO donor, DEA/NO, followed by buffer exchange. ICP-AES of samples treated with 10 mu M DEA/NO showed a decrease in zinc content (0.23 +/- 0.01 to 0.09 +/- 0.01 mol of Zn/mol of iNOS dimer) with no loss of heme iron. Gel filtration of wild-type iNOS treated similarly resulted in similar to 20% more monomeric iNOS compared to a DEA-treated sample. Only wild-type iNOS had decreased activity (42 +/- 2%) after reaction with 50 mu M DEA/NO compared to a control sample. Using the blotin switch method under the sarne conditions, only wild-type iNOS had increased levels of S-biotinylation. S-Biotinylation was mapped to C104 and C109 on wild-type iNOS using LysC digestion and MALDIZ TOF/TOF MS. Immunoprecipitation of iNOS from the mouse rnacrophage cell line, RAW-264.7, and the biotin switch method were used to confirm endo-enOLIS S-nitrosation of iNOS, The data show that S-nitrosation of the zinc tetrathiolate cysteine results in zinc release frorn the dimer interface and formation of inactive monorners, suggesting that this mode of inhibition might occur in vivo.